Krognes Steve E. 4

What Happened

• Steve E. Krognes, a director of Guardant Health, recorded the conversion/vesting of 154 restricted stock units into 154 common shares (transaction code M) on January 31, 2026. The Form 4 shows both an acquisition of 154 shares and a simultaneous disposition of 154 shares at $0.00; no cash consideration is reported.

Key Details

• Transaction date: 2026-01-31 (reported on Form 4 filed 2026-02-02).
• Reported entries: 154 shares acquired @ $0.00 (conversion) and 154 shares disposed @ $0.00 (derivative/ disposition), transaction code M (exercise/conversion of derivative).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes: F1 — These shares stem from an RSU award granted Aug 9, 2022; 25% vested June 30, 2023 and the remaining 75% vests in substantially equal monthly installments over the following three years. F2 — Not applicable for RSUs.
• Filing timeliness: Filed within the Form 4 reporting window (timely).

Context

• This was a vesting/conversion of restricted stock units rather than an open-market buy or sale. Form 4s that show both acquisition and same-day disposition frequently reflect conversion/settlement mechanics (for example, net-share settlement or withholding), but the filing’s footnotes do not explicitly state the reason for the disposition. No cash proceeds or payments are reported for these transactions.